Prof Brigette Ma

Prof Brigette Ma

Prof Brigette Ma is dedicated to the development of innovative early phase clinical trials, novel systemic therapy and treatment guidelines for lower GI and head and neck cancers. She is a member of the European Society of Clinical Oncology (ESMO) Council since 2024 and ESMO Faculty of Developmental Therapeutics group. Prof Ma has a long history of service to influential oncological societies. She is Scientific co-chair of the ESMO Targeted Anti-Cancer Therapy (TAT) Asia meeting and ESMO Advanced Course in Drug Development and served in numerous international societies and committees. In editorial service, she is Editor of Cancer Treatment Review, Associate Editor of Oral Oncology and is member of the Editorial Boards of the Journal of Clinical Oncology, ESMO Open and ESMO Gastrointestinal Oncology. She has published over 230 peer-reviewed papers, including book chapters and high impact journals.